AEON Biopharma, Inc
AEON Biopharma, Inc., located in Irvine, CA, is dedicated to unlocking the therapeutic potential of botulinum toxin for treating various nervous system-related conditions. Their proprietary formulation aims to provide lasting relief to patients suffering from migraines, cervical dystonia, and other disorders through innovative treatment paradigms.
At the forefront of neurotoxin research and development, AEON Biopharma's lead candidate, ABP-450 prabotulinumtoxinA, shows promise in improving the quality of life for individuals affected by nerve and muscle-based disorders. By focusing solely on therapeutic indications, the company positions itself uniquely within the marketplace to deliver impactful treatment options.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
